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Abstract
Nowadays, intervertebral disc (IVD) degeneration is one
of the principal causes of low back pain involving high
expense within the health care system. The long-term goal
is the development of a medical treatment modality focused
on a more biological regeneration of the inner nucleus
pulposus (NP). Hence, interest in the endoscopic
implantation of an injectable material took center stage in
the recent past. We report on the development of a novel
polyurethane (PU) scaffold as a mechanically stable carrier
system for the reimplantation of expanded autologous IVD-
derived cells (disc cells) to stimulate regenerative processes
and restore the chondrocyte-like tissue within the NP.
Primary human disc cells were seeded into newly developed
PU spheroids which were subsequently encapsulated in
fibrin hydrogel. The study aims to analyze adhesion
properties, proliferation capacity and phenotypic
characterization of these cells. Polymerase chain reaction
was carried out to detect the expression of genes specifically
expressed by native IVD cells. Biochemical analyses
showed an increased DNA content, and a progressive
enhancement of total collagen and glycosaminoglycans
(GAG) was observed during cell culture. The results suggest
the synthesis of an appropriate extracellular matrix as well
as a stable mRNA expression of chondrogenic and/or NP
specific markers. In conclusion, the data presented indicate
an alternative medical approach to current treatment options
of degenerated IVD tissue.
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Introduction
Intervertebral disc (IVD) degeneration is an age-related
process affecting the biomechanical properties of the spine
and is assumed to be one of the principal causes of lower
back pain. During disc degeneration, dehydration of the
nucleus pulposus (NP), due to loss of proteoglycans and
disorganization of the extracellular matrix causes an
inefficient transfer of load between the vertebral bodies
leading to further degeneration or even to damage of the
annulus fibrosus (AF) (disc herniation) (Urban and
Roberts, 2003).
Current treatments are highly invasive surgical
procedures such as spinal fusion and discectomy. The
clinical solution is either complete disc removal in
conjunction with spinal interbody fusion or total disc
arthroplasty (Mayer, 2005). Both approaches are not
biological nor do they preserve the natural disc function,
and revision surgery is frequently necessary. In contrast,
biological approaches aim at the stimulation of disc
regeneration (Paesold et al., 2007) to avoid or at least
delay surgical procedures.
A potential alternative could be a tissue engineering
approach to regenerate the inner NP tissue at an early-
stage of the degeneration process. The focus should be
on biocompatible materials that allow three-dimensional
(3D) cell culture and provide initial mechanical stability
after implantation. Thus, cells are given time to synthesize
the extracellular matrix required to resist the compressive
loads caused by daily movements. Moreover, the cellular
scaffold has to promote cell adhesion and integration, and
needs to allow appropriate transport of nutrients and waste
products through the structure. For clinical application it
is crucial that the material can be implanted by minimally
invasive surgery, while cells maintain their viability and
are homogenously distributed.
Different synthetic biomaterials have been studied to
generate in vitro tissue constructs for subsequent disc
augmentation, and are at different levels of preclinical
and clinical investigations (Di Martino et al., 2005).
Studies have been performed using macroporous scaffolds
such as collagen, hyaluronan, calcium phosphates,
polylactide (Yang et al., 2005; Revell et al., 2007; Séguin
et al., 2004; Brown et al., 2005) as well as hydrogels like
fibrin, gelatin, or chitosan (Yang et al., 2005; Bertram et
al., 2005; Roughley et al., 2006; Yang et al., 2008). In the
present study the fibrin glue Tissucol was chosen, focusing
the attention on developing a clinical applicable product
whereby the fibrin is already approved by the Federal Drug
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Agency (FDA) and applied in surgery. Fibrin is a
biocompatible, microporous structure which enables cell
migration as well as diffusion of cell signaling factors and
waste products. The hydrogel is injectable and polymerizes
in vivo at body temperature due to a combination of
fibrinogen and thrombin components. Despite these
advantages, fibrin gel lacks biomechanical resistance and
chemical stability concerning spinal load. As demonstrated
in various studies in cartilage regeneration (Peretti et al.,
2000; Caterson et al., 2001; Lee et al., 2005; Eyrich et al.,
2007a), fibrin needs to be combined with a more stable
material. Here, we combined fibrin hydrogel with
polyurethane (PU) in spherical form to provide a suitable
structure for isolated human disc cells.
The PU we used provides a macroporous,
biocompatible and biodegradable system with sufficient
elasticity, and stiffness to resist compressive loading while
maintaining structural integrity (Eyrich et al., 2007b).
Indeed, PU has been used as a cancellous bone graft
substitute in animals and as a scaffold in cartilage tissue
engineering (Lee et al., 2005; Gogolewski et al., 2006;
Gogolewski et al., 2007; Liu et al., 2004; Grad et al., 2006;
Guelcher et al., 2006). Yang et al. (2009) selected PU
material as a scaffold to regenerate the annulus fibrosus,
demonstrating that the modulation of the PU surface
chemistry can influence cell adhesion and early tissue
formation. Thus, the PU foam provides an initial cell carrier
matrix to resist the mechanical load immediately after
implantation, while fibrin acts as a space-filling compound
and 3D structure to retain cells at the injection site and
maintain their characteristic phenotype.
Hence the study presents the assessment of the
applicability of the PU-fibrin structure designed for
intervertebral disc augmentation. Therefore, human disc
cells were monolayer-expanded in vitro and cultured in
two different 3D culture systems, the PU-fibrin structure
and a pellet culture system. Cell adhesion, proliferation
capacity as well as phenotypic cell characterization were
carefully analyzed.
Materials and Methods
Cell isolation and expansion
Intervertebral disc tissue was obtained during discectomy
of human donors at the University Hospital Balgrist. The
approval of the local ethical committee was obtained for
the use of the samples. The biopsy was transported on ice
in Dulbecco’s Modified Eagle Medium (DMEM)
containing F12 and 1% antibiotic-antimicotic solution
(AAS) (InVitrogen Gibco, Basel, Switzerland). The biopsy
was washed twice in sterile phosphate-buffered saline
(PBS) immediately before being minced into pieces. Tissue
samples were weighed and digested at 37°C for 16 hours
with 0.025% (w/v) NB4 collagenase (Serva
Electrophoresis, Heidelberg, Germany) in DMEM/F12
containing 1% AAS. Afterwards cell suspension was
filtered through a 70mm cell strainer (Falcon, Becton
Dickinson, Allschwil, Switzerland) and centrifuged at
200xg for 10 minutes. Cell viability was assessed by the
trypan blue dye-exclusion assay. Human disc cells (2x103
cells/cm2) were then expanded in monolayer culture using
DMEM/F12 supplemented with 5% fetal bovine serum
(FBS) (Gibco), 1% penicillin/streptomycin solution (PSS)
(Sigma-Aldrich, Basel Switzerland), 5ng/mL basic
fibroblast growth factor (bFGF) (Invitrogen) and 1ng/mL
transforming growth factor (TGF)-b1 (Lubioscience,
Lucerne, Switzerland), and cultured at 37°C and 5% CO
2
for about 14 days until reaching confluence. The medium
was changed every second to third day.
Pellet culture
The pellet system was selected as positive control in the
gene expression studies, which were performed in order
to confirm the redifferentiation of disc cells after the
monolayer cultivation. Therefore, disc cells were harvested
after proliferation and pellet formation was induced as
follows: 5x105 cells were suspended in 3mL of
differentiation medium containing DMEM high glucose
(Gibco), 1% PSS, 1% solution containing insulin, human
transferrin, and selenous acid (ITS) (BD Biosciences,
Allschwil, Switzerland), 150μM ascorbic acid-2 phosphate
(ASC) (Sigma), 100nM dexamethasone (Dex) (Sigma),
1mM sodium pyruvate (Sigma) and 10ng/mL TGF-b1. The
cell suspension was gently centrifuged at 200xg for 3
minutes in polystyrene tubes to form pellets. Cell culture
was performed over 14 days and the medium was changed
every second day.
Polyurethane scaffolds
PU scaffolds were synthesized and kindly provided by
polyMaterials AG (Kaufbeuren) (Wiese and Maier, 2006).
Porous and interconnective foamy PU structures with a
hydrophobic surface were prepared as follows: 3g of
poly(caprolactone) diol (Mn=2000g/mol, Acros Organics,
Belgium) and 3g of poly(caprolactone) triol (crosslinker,
Mn=900g/mol, Acros Organics) were melted and mixed
at 40°C. 100mg of mannitol (Acros Organics) as nucleating
agent, 1g of methylal as blowing agent (Sigma), and 1.5g
isophorone diisocyanate (Sigma) were added and mixed.
The reaction was started by adding 50mL of 1.8-
diazabicyclo[5.4.0]undec-7-en (Acros Organics) and
mixing vigorously. The foam was cured at 65°C after one
hour. The isophorone diisocyanate was added in a slight
excess because of side reactions (e.g. allophanate reaction)
increasing the crosslinking degree and leading to a higher
stiffness of the polymer. The PU foam had a porosity of
80% with pore size of 80 to 300mm and high
interconnectivity.
For cell culture experiments the PU foam structure was
minced into pieces using a Dispomix® (Axon Lab AG,
Baden-Dettwill, Switzerland) tabletop homogenizer with
a predefined profile (20 seconds at the rotational speed of
4000 rpm and 5 seconds at 4000 rpm in the opposite
direction). The obtained spheroids were observed under
the stereomicroscope showing an average particle size of
1±0.4 mm in diameter. PU scaffolds were vacuum-dried
and distributed in 96-well plates (5mg PU/well = 88.21±
26.05 PU spheroids/well). The PU spheroids were then
sterilized in 75% ethanol for 60 minutes followed by three
wash steps in sterile bidistilled water.
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Fibrin hydrogel
TISSUCOL Duo S immuno kit (Baxter Biosurgery,
Volketswil, Switzerland) was used to prepare the fibrin
hydrogel which served as connective material between PU
foam spheroids and provided a biocompatible, injectable
extracellular matrix. The product components were mixed
as described in the manufacturer’s instructions leading to
a final concentration of 70-110mg/mL fibrinogen, 500 IU/
mL thrombin (human), and 3000 KIU/mL aprotinin
(bovine).
Cell seeding and preparation of PU-fibrin structure
After proliferation in monolayer culture, 1.2x105 disc cells
were suspended in 100μl of proliferation medium (DMEM/
F12 supplemented with 5% FBS, 1% PSS, 5ng/mL FGF,
1ng/mL TGF-β1 and 130μM ASC), and dynamically
seeded directly onto 5mg PU spheroids per well, which
had been pre-incubated over night with 5% serum
containing medium to improve cellular adhesion. In
particular, cells were seeded onto PU particles in
suspension and incubated for 30 minutes. Subsequently,
the cell suspension was mixed to avoid cell sedimentation
and stimulate the adhesion onto PU spheroids. This
procedure was repeated one more time before adding fresh
proliferation medium (150μl/well). In order to measure
the efficiency of the dynamic seeding procedure, PU
samples were transferred into new wells, and the remaining
non-adhered cells were counted. These seeded PU
spheroids were pre-cultured for 3 days in proliferation
medium and then embedded in fibrin hydrogel (130μl
fibrin/5mg PU). The samples were incubated for one hour
at 37°C to permit gelation. Afterwards the structures (height
6.5-7mm x diameter 8.6mm) were transferred to 24 well
plates and covered with 1.2mL differentiation medium. The
day of fibrin supplementation to PU spheroids was defined
as day 0 of analysis. The structures were cultured for 3, 7
and 14 days, and medium was changed every second day.
Histological analysis
In order to visualize cell adhesion on PU itself, spheroids
seeded with disc cells were analyzed at day 0 and 14 of
culture. Samples were gently washed with PBS, fixed in
3.7% formaldehyde and washed again with PBS before
staining with 4',6-diamidino-2-phenylindole (DAPI) (1μg/
mL). The stained PU spheroids were analyzed using
fluorescence microscopy (Axioskop 2 plus microscope
equipped with the Axio Cam color camera, Zeiss,
Göttingen, Germany).
Moreover, cells were mixed directly into fibrin and,
cultivated under the same conditions as PU-fibrin
structures. The cell distribution was analyzed by DAPI
staining. In particular cell containing fibrin gels (day 0
and 14) as well as PU-fibrin composites (day 3, 7 and 14)
were fixed in 3.7% formaldehyde and gently rinsed three
times with PBS. The structures were then shock frozen in
liquid nitrogen and 20μm thin sections were prepared by
sectioning in the Cryostat HM 550 OMP (Thermo
Scientific, Waltham, MA, USA). Nuclei were stained with
DAPI as previously described. The samples were observed
using light and fluorescence microscopy.
Biochemical analysis
On days 3, 7 and 14 of culture PU-fibrin structures were
digested in papain (Sigma) solution (28mg/mL) for 6 hours
at 58°C. Total DNA content was determined by the Hoechst
33258 dye (Roche, Basel Switzerland) assay on an aliquot
of the digested sample using a plate reader (UV-visible
spectrophotometer, Cary 50 Scan; Varian, Palo Alto, CA,
USA) at 355nm excitation wavelength and 460nm
emission wavelength. The DNA content of each sample
was quantified by interpolating values from a linear
standard curve generated from calf thymus DNA.
Total sulfated glycosaminoglycan (GAG) content as
well as the collagen amount was assessed in the same
digestion supernatant. GAG amount was measured in a
dimethylmethylene blue (Fluka; Sigma) buffer solution
(pH 3.0). Absorbance was measured at 630 nm and a
standard curve was generated using chondroitin-4-sulfate
(Barbosa et al., 2003). The GAG to DNA ratio was
determined by dividing GAG (μg) by DNA (μg) per each
digested PU-fibrin structure.
Collagen content was detected using the chloramine-
T staining method. Briefly, samples were hydrolyzed with
10M NaOH, neutralized and stained with chloramine-T
solution (Sigma). Absorption was measured at 540nm. The
total collagen content was quantified by interpolating
values (μg) from a linear standard of gelatin-hydrolyzate
(Sigma) (Hoemann et al., 2002). The collagen to DNA
ratio was determined by dividing collagen (μg) by DNA
(μg) per each digested sample.
Gene expression analysis
Phenotypic characterization was performed with fresh
biopsy (100mg), monolayer cultures of isolated human
disc cells (106 cells) (after 10 days), and also with pellet
cultures (after 14 days) and PU-fibrin composites (after
14 days). Cells were lysed in TRIzol reagent (Invitrogen)
and total cellular RNA was isolated in accordance with
the recommendations of the manufacturer. For biopsy
samples and the PU-fibrin composites, the samples were
furthermore mechanically homogenized in Trizol using the
Dispomix®. The purified samples were extracted by
phenol/chloroform, precipitated with isopropanol, washed
with 70% ethanol and resuspended in RNase-free water.
RNA concentrations were assessed spectrophotometrically
(UV-visible spectrophotometer, Cary 50 Scan, Varian) at
260nm. 400ng of total RNA was reverse transcribed
(SuperscriptTM II, Invitrogen) and analyzed by Reverse
Transcriptase-PCR (RT-PCR) (Hotstar Taq DNA
polymerase; Qiagen, Hilden, Germany) using gene-
specific primers (Table 1) for collagen 1 (Col1α1), collagen
II (Col2α1), aggrecan and transcription factor Sox9 (Lin
et al., 2005), hypoxia inducible factor-1 (HIF) 1α isoform
(Gao et al., 2005), metalloproteinase-2 (MMP2) (Shan et
al., 2005), glycosylphosphatidylinositol-anchored cell
surface protein CD24 (Fujita et al., 2005), glucose
transporter (GLUT-1) (Robey et al., 2005), and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as
a housekeeping gene (Sanchez et al., 2005). The PCR
fragments were resolved on a 1.5% agarose gel and stained
with ethidium bromide.
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Figure 1. Human nucleus pulposus-like cells were seeded onto PU spheroids. The cell adhesion has been proven
by DAPI staining. (A) PU spheroids without cells (blank). (B) Nuclei staining of adhered cells onto the PU
material pre-cultured for 3 days with proliferation medium (day 0), observed by fluorescence microscopy, and
(C) overlay with light microscopy. (D) Nuclei staining of disc-like cells after 14 days of culture with differentiation
medium observed by fluorescence microscopy, and (E) overlay with light microscopy.
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Figure 2. Human nucleus pulposus-like cells were seeded in fibrin structures by adding them to the fibrin before
its polymerization. (A) Fibrin structure without cells (blank). (B) Nuclei staining of adhered cells in the matrix,
pre-cultured for 3 days with proliferation medium (day 0), observed by fluorescence microscopy and (C) overlay
with light microscopy. (D) Nuclei staining of disc-like cells after 14 days of culture with differentiation medium
observed by fluorescence microscopy, and (E) overlay with light microscopy.
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Figure 3. DAPI stained cryosections of PU spheroids seeded with human disc-like cells and embedded into fibrin
hydrogel. (A) PU spheroids embedded in fibrin hydrogel without cells (blank). Cell expansion and distribution
into the PU-fibrin structure after (B) 3 days, (D) 7 days and (F) 14 days observed by fluorescence microscopy, and
(C, E, G) overlay with light microscopy. The black arrows indicate the PU spheroids.
33 www.ecmjournal.org
C Mauth et al.                                                                                                                  Intervertebral disc regeneration
Statistical analysis
The statistical significance of total DNA, GAG and
collagen content of PU-fibrin structures after 3, 7 and 14
days in culture were analyzed by ANOVA and the post
hoc Fisher’s PLSD (Protected Least Significant Difference)
test. A p value < 0.05 was considered to be statistically
significant
Results
Cell culture and scaffold characterization
For our experiments 18 biopsies were processed obtaining
an average yield of 2.4 ± 0.6 x 105 cells per g wet weight.
The mean age of the donors was 43.6 ± 17.4 (57% < 40
and 43% > 40 years age; 27% men and 73% women). 68
± 5% of isolated cells were found to adhere to the
polystyrene surface of culture dishes and reached 80%
confluence after 10 days. NP and AF cells were maintained
in co-culture since cross-contamination of NP cells with
AF cells was not avoidable during the discectomy. Thus,
the duration of isolation procedure was minimized, and
closely reflected the procedure that would be used during
the targeted clinical application.
The cell adhesion efficiency onto hydrophobic PU
spheroids was detected 2 hours after seeding. Cell seeded
PU spheroids were transferred to new wells for further
cultivation. The remaining non-adhered cells were counted
and subtracted from the total cell seeding concentration
resulting in an adhesion efficiency of 78 ± 9.6%.  Moreover,
the presence and distribution of cells onto pre-incubated
PU spheroids was analyzed 3 days after the seeding (day
0) and at day 14 using DAPI staining. Samples were
analyzed by fluorescence microscopy (Fig. 1B,D), and
overlaid light microscopy (Fig. 1C,E). Cell distribution
was also investigated in pure fibrin gels at day 0 and 14
demonstrating their homogeneity within the matrix (Fig.
2B-E).
Figure 4. Gene expression
analyses of one culture sample as
example. Total RNA was isolated
from (A) disc biopsy, (B)
monolayer culture after 10 days,
(C) pellet culture, and (D) PU-
fibrin structure after 14 days in
culture. The RNA was subjected to
reverse transcriptase-PCR reaction
and PCR products were resolved
on a 1.5% agarose gel. DNA ladder
of 100bp (lane 1), expression of
collagen type I (lane 2) and type II
(lane 3), aggrecan (lane 4), HIF-1
alpha (lane 5), MMP2 (lane 6),
SOX9 (lane 7), GLUT-1 (lane 8),
CD24 (lane 9) and GAPDH (lane
10).
Figure 5 Biochemical analyses of (A) DNA content, (B) collagen
and (C) GAG to DNA ratio within PU-fibrin structures after 3,
7 and 14 days of culture. The collagen/DNA ratio as well as the
GAG/DNA ratio was determined by dividing the extracellular
matrix component (μg) by DNA (μg) per each PU-fibrin
structure. *p<0.05 compared cultures of 7 versus 3 days, and
14 versus 7 days in culture, respectively.
A B
C
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Three days after cell seeding, PU spheroids were
encapsulated into fibrin (Fig. 3), and cultured for 3, 7 or
14 days. During culture cells proliferated inside the PU-
fibrin structure as demonstrated by DAPI staining of
cryosections (Fig. 3B-G). Moreover, the PU-fibrin
structure remained transparent and stable after 14 days.
Interestingly, while cells were attached to the PU surface
on day 3 (Fig. 3B,C), after 7 days of culture the majority
of the encapsulated cells had become detached from the
PU and distributed into the fibrin structure (Fig. 3D,E).
On day 14, the fibrin matrix was completely penetrated
by cells, resulting in a uniform distribution (Fig. 3F,G).
From day 14 onwards, the role of the PU spheroids in the
composites appeared to be mainly to stabilize the structure
of the 3D culture enhancing the elasticity and the rigidity
of the hydrogel.
Specific gene expression levels of 3D cultured disc
cells
Semi-quantitative PCR was used to investigate the cell
phenotype by analyzing the expression of chondrogenic
(collagen type I and II, aggrecan, and Sox9) and also NP
cell specific mRNA levels (HIF, GLUT-1, MMP-2 and
CD24). Phenotypic profiles were generated either from
disc tissue, monolayer culture, or pellet cultures versus
PU-fibrin structures (3D), an example being shown in
Figure 4.
The biopsy analysis (Fig. 4A) showed similar
expression of Col1α1, Col2α1 and aggrecan. Expression
of Sox-9 could not be displayed. NP markers on the protein
level as MMP-2, GLUT-1, and CD24 showed equal yet
low expression levels, while HIF expression could be
demonstrated.
Table1. Gene specific primers used for PCR amplification 
 
Gene GenBank No Primer sequence (5’ – 3’) Length Tm 
Col I (A1) NM_000088 
Fwd: CAT CTC CCC TTC GTT TTT GA 
Rev: CTG TGG AGG AGG GTT TCA GA 
598 bp 51.0 
Col II (A1) 
NM_033150 
NM_001844 
Fwd: AGC ATT GCC TAT CTG GAC GAA G 
Rev: AGA GTC CTA GAG TGA CTG AG 
361 bp 57.0 
Aggrecan 
NM_013227 
NM_001135 
Fwd: GAG GAG GGC TGG AAC AAG TAC C 
Rev: GGT AAT TGC AGG GAA CAT CAT T 
343 bp 60.0 
HIF-1α 
NM_001530 
NM_181054 
Fwd: AAT GCC ACC ACT ACC ACT GC 
Rev: TAA CAC GTT AGG GCT TCT TGG A 
237 bp 53.0 
MMP-2 NM_004530 
Fwd: AGT CTG AAG AGC GTG AAG TTT G 
Rev: CCA GGT AGG AGT GAG AAT GC 
192 bp 52.0 
SOX9 NM_000346 
Fwd: GAA CGC ACA TCA AGA CGG AG 
Rev: TCT CGT TGA TTT CGC TGC TC 
631 bp 60.0 
GLUT-1 NM_006516 
Fwd: TCA ATG CTG ATG ATG AAC CTG CT 
Rev: GGT GAC ACT TCA CCC ACA TAC A 
164 bp 53.0 
CD24 NM_013230 
Fwd: GCA CTG CTC CTA CCC ACG CAG ATT T 
Rev: GCC TTG GTG GTG GCA TTA GTT GGA T 
122 bp 59.0 
GAPDH NM_002046 
Fwd: TTG GTA TCG TGG AAG GAC TCA 
Rev: TGT CAT CAT ATT TGG CAG GTT T 
270 bp 50.0 
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After expansion of isolated disc cells in monolayer
culture (Fig. 4B), the expression of Col1α1 was observed.
In comparison, Col2α1 was found to be notably decreased
when compared to the respective mRNA levels of biopsy
material. HIF, GLUT-1, MMP-2 and CD24 were expressed,
while Sox9 was not detected. Expression levels were
further analyzed in pellet cultures and compared to cultures
in PU-fibrin structures. In pellet culture (Fig. 4C) a
predominant upregulation of Col2α1 versus Col1α1 was
observed, and also aggrecan was highly expressed. HIF,
MMP, GLUT-1 and CD24 showed no notable changes
compared to monolayer culture. However, Sox9 mRNA
expression was present.
Disc cells encapsulated into PU-fibrin structures also
presented a high expression of extracellular matrix specific
mRNA levels such as Col1α1 and Col2α1, and aggrecan.
HIF, GLUT-1, CD24 and MMP-2 mRNA expression
showed no striking changes compared to pellet cultures.
The expression of Sox9 was the most noticeable (Fig. 4D).
Disc cells cultivated into 3D systems showed a high
capability to reacquire their original phenotype based on
the detected markers. A weak expression of Sox-9 and
Col2α1 was detected in cell seeded PU-fibrin structures
only after 3 days of culture (data not shown), reaching
stronger levels at day 14.
Proliferation ability and extracellular matrix protein
content in PU-fibrin structures
Biochemical analysis of DNA content in cell seeded PU-
fibrin structures confirmed the observations of DAPI
staining (Fig. 3). The DNA content constantly increased
throughout the culture reaching a maximal value of 3.58 ±
0.79μg DNA per PU-fibrin structure after 14 days (Fig.
5A). Cells proliferated during the first 7 days with a DNA
content of 1.71 ± 0.21μg after 3 days, which then
significantly increased (2-fold) within the next 4 days up
to 3.27 ± 0.86μg (Fig. 5A).
The capability of cells to synthesize extracellular matrix
proteins was investigated by analyzing the content of
collagen and glycosaminoglycans (GAG). The collagen
(Fig. 5B) and GAG content (Fig. 5C) per DNA content
showed a substantial time-dependent increase over the
complete culture time. The retained GAG content within
the PU-fibrin structure was measured, whereas content
released into medium was not analyzed. The collagen to
DNA ratio significantly increased (1.9-fold) after 14 days
of culture while remaining constant in the first 7 days of
cell adaptation (Fig. 5B). In contrast, GAG to DNA ratio
increased significantly over the complete culture time (Fig.
5C) reaching a maximum value of 2.5-fold in 11days (day
14 of culture minus day 3 days of pre-culture in
proliferation differentiation medium).
Discussion
Considering the current treatment modalities for disc
degeneration that will generally lead to a loss of function
of the intervertebral disc, a tissue engineered approach
represents a promising strategy for the treatment or even
prevention of painful, mildly to moderately degenerated
discs. However, several issues need to be solved before
potential treatment modalities can be turned into clinical
realities. The biological environment of normal NP with
acidic pH, low oxygen levels and paucity of nutrients make
the construction of 3D functional tissue a very complex
process. The current clinical trials investigate new artificial
biomaterials (ClinicalTrials.gov Identifier NCT00589797,
NCT00215306, NCT00640029), in order to simply
substitute the native IVD, while only one is focusing its
attention on the IVD regeneration. In particular, its purpose
is to demonstrate the effectiveness and safety of a single
intradiscal injection of rhGDF-5, a growth and
differentiation factor, into a degenerating single spinal disc
of patients with early disc degeneration (ClinicalTrials.gov
Identifier NCT00813813).
The aim of the present in vitro study was to investigate
the potential of a polyurethane-fibrin-based cell-seeded
scaffold combination which maintains autologous disc
cells after reimplantation.
A method of direct injection of the cell suspension was
applied into NPs of rabbits to augment mildly degenerated
discs. Even though the procedure seems to be easy to apply,
its success was limited by a low survival rate of the
implanted cells and leakage of cells through the injection
site (Bertram et al., 2005).
To overcome the disadvantages of a simple cell-
solution injection, various studies have been performed
using cells embedded in gel-like matrices (poly-L lactic
acid, gelatin, collagen-hyaluronan, alginate, chitosan,
fibrin) (Brown et al., 2005; Roughley et al., 2006; Halloran
et al., 2008; Richardson et al., 2006; Kluba et al., 2005;
Yang et al., 2008). Although these studies revealed that
the correct matrix formation (including aggrecan, collagen
type I and II) can be displayed in the matrix material, the
hydrogels do not supply the required initial mechanical
stability to the implanted structure.
Hence, augmenting a degenerated NP by applying a
cell-seeded biomaterial might be a more successful
approach. Various materials have been studied in vitro,
and cultured with animal or human cells obtained either
from the AF or NP (Yang et al., 2005; Revell et al., 2007;
Halloran et al., 2008; Kluba et al., 2005; Gruber et al.,
2004). However, most of the materials tested so far fulfill
only some of the criteria required but fail in others. In
summary, fundamental criteria focusing on intervertebral
disc regeneration are: (i) physical and mechanical stability
for load-bearing applications but also suitable for minimal
invasive surgery if not even injectable without cell
depletion; (ii) ability to carry cells and allow sufficient
cell attachment, proliferation, and migration into the
surrounding matrix; (iii) enhancement of extracellular
matrix synthesis to allow tissue formation and remodeling,
and (iv) biocompatibility (Chan and Leong, 2008). The
ultimate goal of such a scaffold is to unify the criteria
posing a challenge to be born.
In order to unite the advantages, in the present study a
material structure was applied which combines crucial
properties for clinical use: injectable, porous, shape-stable,
biologically degradable and biocompatible. At the
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beginning of our study, preconditioned PU spheroids were
shown to enable cell adhesion and proliferation. However,
it is believed that synthesized proteins diffuse out of the
highly porous structure and cannot be sufficiently
incorporated into the extracellular matrix, resulting in a
prolonged limiting effect of the material (Grad et al., 2003).
Here, spheroids were combined with fibrin hydrogel and
already showed in the first week of culture a migration
from PU particles into the fibrin matrix. After two weeks
cells reached a homogenous distribution within the
composite comparable to cells cultured in pure fibrin.
Eyrich et al. (2007b) and Lee et al. (2005) observed a
similar material combination for use in cartilage tissue
engineering and found it advantageous due to improved
cell distribution and extensive development of extracellular
matrix.
Similar to previous studies, performed on human and
canine disc cells within hydrogel carriers, our results
showed the ability of the disc cells to synthesize
extracellular matrix into fibrin and thus a biosynthetic
behavior comparable to that of cells in native tissue (Gruber
et al., 2004; Rong et al., 2002). Moreover, unlike those
studies, the fibrin was combined with PU spheroids in order
to supply more elasticity, resistance and rigidity to the
implants for further clinical applications.
In our experiments, we were able to show increased
collagen content as a major component of the extracellular
matrix. In addition, GAG content was increased in the
scaffold over time, therefore indicating increased capacity
for water retention, an important feature of the NP in vivo.
However, it is noted that GAG content was not determined
in medium supernatant since a substantial amount of GAG
might have diffused into the medium, as demonstrated by
Lee et al. (2005). The augmentation of the extracellular
matrix, a complex and stable network of proteoglycans
(predominantly aggrecan) and collagen, plays an important
role in withstanding in vivo mechanical loading and is
therefore an important variable to be determined for novel
biomaterials.
Besides the ability to synthesize collagen and GAG, a
more detailed phenotypic characterization of the cells is
necessary, especially when the fact that intervertebral disc
cells are prone to dedifferentiation during monolayer
expansion is taken into consideration. It was previously
shown by Kluba et al. (2005) that collagen type II
expression is reduced during monolayer culture, a finding
that we were able to confirm. However, it is known that
disc cell culture in appropriate 3D structures as the pellet
system may at least partly revert to their original features
(Gan et al., 2003). Thus, gene expression of several
chondrocytic and/or disc cell markers were analyzed in
disc explants, cells expanded in monolayer as well as cells
cultured on the PU-fibrin scaffold and in pellet culture.
Expansion of autologous disc cells is required since
the source of cells during discectomy is quite limited.
However, we found severe alterations in the gene
expression profile after monolayer expansion. While
aggrecan expression remained unchanged in all culture
systems, substantial changes were found for collagen
expression. Collagen type II expression of biopsies was
downregulated during monolayer expansion, data obtained
being similar to that presented by Kluba et al. (2005).
However, we were able to demonstrate clearly that collagen
type II expression in 3D cultures, PU-fibrin structure and
pellet was upregulated compared to monolayer cultures.
We also analyzed disc cell cultures in respect of their
ability to redifferentiate not only by detecting matrix-
related markers but also by NP-specific mRNA expression.
Although different markers have been suggested for NP
cells in the last few years, no ideal single marker has been
identified so far, thus leading to the conclusion that the
expression of a set of genes needs to be analyzed, such as
HIF-1 (hypoxia induced factor) (Rajpurohit et al., 2002),
GLUT-1 (glucose transporter) (Rajpurohit et al., 2002),
MMP2 (matrix metalloproteinase 2) (Rajpurohit et al.,
2002), CD24 (glycosylphosphat-idylinositol-anchored cell
surface protein) (Fujita et al., 2005) and Sox9 (Paul et al.,
2003). Both HIF-1 and GLUT-1 are related to the NP
metabolic activity. The data presented show expressions
of HIF-1, GLUT-1 and CD24 before and after isolation as
well as monolayer-expansion when seeded into the PU-
fibrin material combination, indicating that all the cultures
analyzed maintain their phenotypic character.
MMP-2 was also measured and found to increase
slightly during 3D cultures, potentially indicating the
induction of remodeling processes, characterized by matrix
formation of disc cells and degradation of fibrin structure.
The reason of MMP2 expression in addition during
monolayer culture is not yet known. Even more interesting
is the expression of Sox9 in 3D cultures. Paul et al. (2003)
studied the potential use of a recombinant adenoviral vector
expressing Sox9 in human disc cells among others. It was
shown that the expression of the chondrocyte-specific
transcription factor clearly stimulated collagen type II
synthesis in vitro. These mRNA level data also reflect our
findings of increased matrix proteins (total collagen and
aggrecan content). Thus, initial expression of Sox9 and
collagen type II after 14 days may indicate the synthesis
of an appropriate extracellular matrix.
The long-term goal of this study was to develop new
regenerative treatment options for degenerated disc
augmentation using cell-seeded biomaterial for a minimal
invasive reimplantation via an arthroscopic procedure. As
a first step, we demonstrated the suitability of a PU-fibrin
biomaterial structure as a carrier scaffold for disc cells. In
this current setting, disc cells are isolated from biopsies
and expanded in monolayer before being seeded into the
scaffold and combined with fibrin hydrogel for
reimplantation. Therefore, short expansion periods are
necessary to avoid severe dedifferentiation and to create a
reasonable time for patients between the first surgery
(discectomy) and the reimplantation. We were able to show
that cells redifferentiate in PU-fibrin composites based on
the presented marker design, underlining the fact that it is
not the initial number of implanted cells which is decisive
(Nomura et al., 2001). Instead, the ability to synthesize
and incorporate extracellular matrix protein into the
scaffold seems to be more important.
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Conclusion
The current study provides first evidence that the polymer-
fibrin structure developed is suitable to augment early-
stage degenerated intervertebral disc. The idea at the base
of this study was to generate a 3D system able to supply
the degenerated nucleus pulposus with autologous fresh
cells, in vitro expanded, and so to restore the spine
properties. The injectability of the fibrin as well as the
resistance of the PU makes of this model a potential
candidate for the IVD tissue engineering. Moreover, human
disc cells cultivated in the PU-fibrin material, reaching a
homogenous 3D distribution in the fibrin, re-acquired their
original phenotype and capability to synthesize
extracellular matrix molecules. Even though further
optimizations are necessary before the translation of this
promising approach into a widely applicable treatment
modality, our results indicate the potential to lay the base
for an advanced, cost-efficient and minimally invasive cell-
therapeutic approach which takes medical needs into
account.
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Discussion with Reviewers
Reviewer I: It is known that fibrin is degraded by
proteolytic enzymes that may be released by the cells. Thus
it can be assumed that the fibrin structure might be
weakened after 14 days of culture in medium without
proteinase inhibitor. Was any degradation of the fibrin
component observed after 14 days of culture?
Authors: The cell seeded PU-fibrin composites, after two
weeks of culture, did not show any morphological
difference compared to non-seeded structures (blank
samples). Moreover, composites cultured for 3 and 7 days
also showed a stable structure. Certainly, for a longer period
of culture, the fibrin is degraded but at the same time it
would be replaced with extracellular matrix components,
which as shown in the present study are synthesized in the
first weeks of culture.
Reviewer I: Was the capability of proliferation and matrix
synthesis (DNA, GAG, collagen content) different in cells
from donors <40 years versus donors >40 years of age?
Reviewer III: How did the age of the patient and the degree
of degeneration of the IVD influence the outcome of the
cell culture?
Authors: With age, similar as in cases of degeneration,
the IVD undergoes a variety of changes with a lower
39 www.ecmjournal.org
C Mauth et al.                                                                                                                  Intervertebral disc regeneration
synthesis and accumulation of the extracellular matrix
proteins as collagen and aggrecan, and increasing levels
of degrading enzymes. Intervertebral disc cells isolated
from younger donors proliferated faster versus the older
ones. Regarding cell capability to synthesize extracellular
matrix proteins, it is, however, necessary to mention that
the IVD degeneration level as well as the health state of
the patient influences the disc-cell metabolism. Because
of the high variability of the condition of the donors a
final conclusion on the age effects on cell biosynthesis
cannot be drawn. However, we could hypothesize that
better results can be obtained with the use of cells isolated
from young/healthy discs. A recent in vitro study,
performed on disc cells isolated from bovine caudal spines,
has demonstrated that mature cells are not able to
synthesize extracellular matrix at the same level as younger
cells (Kandel et al., 2007).
Reviewer I: Can the authors comment on the effect of the
chondrogenic supplements TGF-β and dexamethasone on
gene expression and matrix synthesis? Was re-
differentiation of disc cells in the 3D environment also
investigated in control cultures without chondrogenic
supplements?
Authors: All culture experiments were performed with
TGF-β and dexamethasone. As known in the literature,
TGF-β and dexamethasone, acting as anabolic regulators
of disc cell metabolism, are able to increase and maintain
the cell chondrocyte-like phenotype. Because of this
knowledge and of our know-how on the maintenance of
the chondrogenic metabolism of disc cells in pellet cultures,
we decided to enrich the culture medium with the
supplements mentioned. Our final aim was to optimize
the in vitro experimental conditions and compare our
models to an established positive control (pellet system).
Reviewer III: How would the application of pressure to
the cell culture influence the maturation of matrix and
cells?
Authors: Under physiological conditions, the IVD is daily
exposed to different and complex physical stimuli during
mechanical loads such as compressive and shear stresses,
osmotic and hydrostatic pressure. Intense work, in vitro
and in vivo, demonstrated that disc cells responses depend
on pressure magnitude, frequency as well as on the loading
type. High magnitude or frequency of loading induce
catabolic cell responses with down-regulation of matrix
forming and up-regulation of matrix degrading enzymes,
cell death and degeneration; while low mechanical
applications give rise to a stimulatory effect on
biosynthesis, improving the expression of collagen and
proteoglycans.
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